CorMedix Inc.
June 23, 2025 - by Joey Ramson
$CRMD shares are up today and leading the Prism MarketView Pharmaceuticals index after raising their revenue forecast as a result of a Large Dialysis Organization customer ordering its DefenCath product, which is used for the prevention of catheter-related bloodstream infections.
